Aims/hypothesis The involvement of chronic inflammation in albuminuria and renal function was investigated in a crosssectional study of 320 type 2 diabetic Chinese patients from the Singapore Diabetes Cohort Study. Methods Plasma levels of TNF-α and its two cellular receptors and of IL-6 and C-reactive protein (CRP) were measured. A composite TNF-α score was extracted using principal component analysis. Multiple linear regression analysis was implemented to evaluate the relationship between log e (ln) albumin:creatinine ratio (ACR) and estimated GFR (eGFR) with the inflammatory variables and other clinical covariates. A Bonferroni correction was applied based on the total number of variables entered into regression analyses.
traditionally been conceived as a process that stems from macrophage infiltration, more recent evidence suggests that even cells distant from the blood stream, such as podocytes, can produce inflammatory cytokines [2] . Indeed, preliminary observations of a systemic inflammation have been reported in diabetic patients with diabetic nephropathy. Specifically, albuminuria in both type 1 and type 2 diabetic patients has been associated with serum levels of TNF-α, IL-6 and C-reactive protein (CRP) [1, 3] .
While albuminuria has been the primary endpoint of interest in these studies, it is much less clear whether this pro-inflammatory response is also implicated in the modulation of GFR, a measure of renal function. This aspect is particularly of interest with newer insights from genetic studies that provocatively suggest that variation in albuminuria and GFR are possibly two different underlying phenotypes in diabetic nephropathy [4, 5] . Extending this hypothesis, various risk factors may play a role in causing either phenotype, or even both [6] . With a mind to the above, we have here set out to clarify whether systemic inflammation is associated with variation in both albuminuria and GFR in type 2 diabetes in a sample of 320 type 2 diabetic Chinese patients residing in Singapore.
Methods
Patients Type 2 diabetic Chinese patients included in this study were from among patients recruited into the Singapore Diabetes Cohort Study (SDCS). The research protocol was approved by both the National University of Singapore Institutional Review Board (NUS-012) and the National Healthcare Group Domain-Specific Review Board (C/05/ 118) and patients participating in this study gave informed consent. Briefly, since 2004 all patients previously diagnosed with type 2 diabetes and who were being treated at primary care facilities of the National Healthcare Group Polyclinics in Singapore were invited to join the SDCS. Of the patients approached, 91% agreed to participate in the study and formed a part of our SDCS patient group. Consenting patients completed a questionnaire to elicit information on demographics, lifestyle factors and medical family history and also had their physical measurements taken. Blood and spot urine specimens were obtained for laboratory analyses and medical records were reviewed to obtain information on their metabolic control and the presence of comorbidities and complications. A sample of 320 patients with fasting blood specimens was available at the time of this study. Only Chinese patients were included in this present study.
Laboratory measurements CRP was measured by an ultrasensitive competitive immunoassay, as described previously [7] . IL-6 was measured by an ELISA (Quantikine IL-6; R&D Systems, Oxford, UK) as described previously [8] . TNF-α was measured by enzyme immunoassay (Quantikine HS Human TNF-α immunoassay; R&D systems, Minneapolis, MN, USA) as previously described, and the soluble forms of its two cellular receptors, sTNFR1 and sTNFR2, were measured by ELISAs (Quantikine Human sTNFR1 and sTNFR2 immunoassays; R&D Systems, Minneapolis) [9, 10] . Further, the Pearson's correlation coefficient was estimated to evaluate the strength of relationship between continuous outcomes of interest. A composite score of TNF-α, sTNFR1 and sTNFR2 was extracted using principal component analysis with varimax rotation. Since the three molecules of the TNF-α system were highly correlated, the composite score was subsequently used in the multiple linear regression analysis when assessing the relationship of ln ACR and eGFR with inflammatory cytokines (namely, IL-6, CRP and composite TNF-α score). In our reasoning, a composite TNF-α score may potentially represent a useful way of summarising the information provided by all three molecules of the TNF-α system. At the same time, using the TNF-α score bypassed the problem of multi-collinearity if TNF-α, sTNFR1 and sTNFR2 were included simultaneously in regression analyses. TNF-α score correlated most strongly with sTNFR2, followed by sTNFR1 and last, TNF-α (Electronic Supplementary Material [ESM] Fig. 1 ). As supplementary analyses, regression was repeated considering only one molecule of the TNF-α system at a time while excluding the others. As assessed by the fit of the regression models (R 2 ), the TNF-α score appeared to perform better than TNF-α alone, and was comparable to the individual receptors (ESM Tables 1, 2 , 3, 4, 5, 6) .
Statistical analyses
Multiple linear regression analysis was implemented to evaluate the relationship between ln ACR and eGFR with potential risk factors. Besides the inflammatory variables (IL-6, CRP and TNF-α score), the covariates that were initially considered in the regression analyses were age at recruitment, sex, diabetes duration, BMI, WHR, HbA 1c , ln triacylglycerol, MAP, total cholesterol, LDL-cholesterol, HDL-cholesterol and diabetes treatment modality. For the variable selection, nested models were compared using the F statistic. Bonferroni corrections were applied based on the total number of inflammatory variables and covariates tested. A Bonferroni-corrected p value (p c ) <0.05 was considered statistically significant.
Results

Patient characteristics
Selected characteristics of the 320 study patients are shown in Table 1 . Both sexes were similar in all the various measurements except that females had smaller WHRs (p c <0.05) and higher HDL-cholesterol levels (p c <0.05). Serum CRP levels were also higher among females compared with males (p c < 0.05). The two renal measurements (i.e. ln ACR and eGFR) were only modestly correlated (Pearson's correlation coefficient r value −0.204, uncorrected p<0.001) (Fig. 1 ).
Inflammatory molecules Plasma levels of five inflammatory molecules of interest (IL-6, CRP, TNF-α, sTNFR1 and sTNFR2) were measured. The presence of these molecules were correlated with each other with r values ranging from a modest 0.203 (ln CRP vs TNF-α), to a higher 0.835 (sTNFR1 vs sTNFR2) (Fig. 1 ). As anticipated, the three molecules of the TNF-α system (which included TNF-α and its two receptors) were also highly correlated with r>0.649 (Fig. 1) .
Association of plasma inflammatory markers and covariates with albuminuria (ACR) In the multivariate analyses, ln ACR was significantly associated with TNF-α score, with a unit change in TNF-α score resulting in a 0.20 unit change in ln ACR (ACR in g/kg) (95% CI 0.13-0.27, uncorrected p<0.001). This association between ln ACR and TNF-α score persisted regardless of whether eGFR was excluded (Model 1) or deliberately retained (Model 2) in the model (Table 2 ). This association remained significant even after correction for multiple testing (p c <0.05) ( Table 2 ). Multivariate analyses considering the individual molecules of the TNF-α system alone instead of the composite TNF-α score yielded similar results (ESM Tables 1, 2, 3) . Neither CRP nor IL-6 levels were associated with ln ACR (uncorrected p>0.05) ( Table 2 ). This lack of association with IL-6 and CRP was evident even in regression analyses that excluded TNF-α score (data not shown). Among the covariates, only diabetes duration showed a clear association with ln ACR after taking into Table 2) .
Association of plasma inflammatory markers with eGFR
We next hypothesised that the inflammatory markers studied might be associated with eGFR independently of ln ACR. To test this possibility, we repeated the regression analyses with eGFR as the dependent variable ( Table 3) . The TNF-α score was associated with eGFR whether in the absence (Model 1) or with deliberate retention of ln ACR as a covariate (Model 2) (Table 3) ; this association remained significant even after correction for multiple testing (p c <0.05). On average, a unit increase in TNF-α score is associated with a reduction in eGFR of 12 units (95% CI 9-14).
Multivariate analyses considering the individual molecules of the TNF-α system alone instead of the composite TNF-α score yielded similar results (ESM Tables 4, 5, 6 ). Neither IL-6 nor CRP showed any significant association with eGFR (uncorrected p>0.05), even with the exclusion of TNF-α score from the regression analyses (data not shown). In contrast to our analyses with ln ACR as the outcome variable, age was the only covariate that showed significant evidence for association with eGFR (uncorrected p<0.001; p c <0.05) ( Table 3) . Although the type of diabetes treatment modality was associated with the various TNF variables (namely, TNF-α score, TNF-α, sTNFR1 and sTNFR2) Table 7 ), it did not emerge as significant predictor of either ln ACR or eGFR in regression analyses.
Discussion
In this present study, we sought to investigate the potential role of inflammation in modulating albuminuria and eGFR in Chinese patients with type 2 diabetes. Our most salient finding was that activation of the TNF-α system was strongly implicated in both renal traits (ln ACR and eGFR). Moreover, this pro-inflammatory effect on one trait was clearly independent of its effect on the other (Tables 2, 3) . Given the correlation between ln ACR and eGFR ( Fig. 1) , this intriguing finding would suggest that although there may be evidence of a systemic inflammation mediated by the TNF-α system in type 2 diabetic patients, the phenotypic manifestation of this underlying process may be distinct. Specifically, some of these patients may manifest albuminuria, while in others there may be an early decline in renal function instead. This observation may suggest that environmental or even genetic factors could potentially influence the association between the TNF-α system and these renal traits. The growing realisation that genetic modulation of albuminuria and impaired renal function may be attributed to different chromosomal susceptibility loci would at least seem to be consistent with this notion [4, 5] . In human studies, the involvement of TNF-α in diabetic nephropathy has primarily been confined to its association with albuminuria [2] . Specifically, serum TNF-α was associated with albuminuria in a pilot study of 65 type 2 diabetic patients [12] . This finding has since been confirmed in a subsequent larger study of 160 diabetic patients [3] . Such a positive association has similarly been reported among type 2 diabetic Japanese patients [13] as well as in Europids with type 1 diabetes [14] . In experimental models of diabetes, urinary albumin excretion has been correlated with urinary levels of TNF-α and with renal TNF-α (also known as TNF) gene expression [15, 16] . Inhibition of TNF-α using two different modalities (the monoclonal antibody infliximab and the p38 mitogen-activated protein kinase inhibitor FR167653) ameliorated urinary albumin excretion with a concomitant reduction in TNF-α excretion in a streptozotocin-induced rat model of diabetes [17] . Taken together, these previous results from both human and animal studies corroborate our present positive findings that the activation of the TNF-α system is very likely implicated in diabetes-induced albuminuria.
In contrast to the literature on albuminuria, much less is known about the possible effect of the TNF-α system on eGFR in diabetes. Indeed, in our literature review, we came across only one report so far and this was based on a crosssectional analysis of the Health Professionals Follow-Up Study (HPFS). Although that study did find an association between serum levels of sTNFR2 and eGFR in type 2 diabetes [18] , there are a couple of important caveats. First, because of the study design, that association was only restricted to men. Second, the potential confounding effect of albuminuria on the association between sTNFR2 levels and eGFR was not evaluated. Also, the statistical significance of the association was not corrected for multiple hypothesis testing. These deficiencies have now been addressed in our present study.
The potential involvement of the TNF-α system in the impairment of renal function may be glimpsed from other studies that have not primarily focused on diabetes [19, 20] . Higher TNFR2 levels have been associated with reduced renal function among predominantly non-diabetic individuals with a history of myocardial infarction [19] . In rodent models, neutralisation of TNF-α by administration of its soluble receptor (TNFsRp55) ameliorated the loss in GFR brought on by i.p. injection of bacterial lipopolysaccharide [20] . This detrimental effect of TNF-α on renal dysfunction may be potentially mediated by the effect of this cytokine on the transcriptional regulation of the potent vasoconstrictor endothelin-1 in endothelial and mesangial cells of the glomerulus [21] , possibly in concert with a profound alteration in gene expression of various renal glucose transporters including sodium-dependent co-transporters SGLT1, -2 and -3 (also known as SLC5A1, -2 and -3, respectively), as well as the glucose transporters GLUT1 (also known as SLC2A1) and GLUT2 (also known as SLC2A1) [22] . Our findings with regard to other inflammatory molecules, IL-6 and CRP, were less convincing in comparison to the TNF-α system. We did not observe any association of IL-6 with albuminuria. This result differed from the earlier findings among type 1 diabetic Europids by Saraheimo et al. [1] This discordance may be due to differences in ethnicity and type of diabetes. It is also unclear if the reported association with IL-6 would have remained statistically significant after correction for multiple hypotheses testing. Of relevance, another previous study had failed to find any significant association of serum IL-6 with raised albumin excretion rates in a study of 72 type 1 diabetic Europids [23] .
It has been proposed that CRP may be associated with albuminuria in a study of 194 type 1 diabetic Europids, but since that finding was only borderline significant (uncorrected p=0.016) [1] , it may still be compatible with our current negative results. With respect to eGFR, our CRP findings were concordant with the reported findings from the cross-sectional analysis of 732 type 2 diabetic men in the HPFS [18] . It was noted in our study that plasma CRP levels were higher in women compared with men, an observation that was consistent with previous reports on diabetic patients [24, 25] . The reason for this sex difference has not been clearly established, although it may be related to the use of oral contraceptive pills [25] . Since information on the use of oral contraceptives was not captured in our study population, this association cannot be confirmed at the moment.
The primary focus of our study has been to examine the possible role of inflammation in diabetic nephropathy. Nevertheless, our concomitant covariate analyses did also highlight several notable findings. Diabetes duration was strikingly associated with ln ACR but not eGFR. On the other hand, age was significantly associated with eGFR, but not ln ACR.
Our study is not devoid of shortcomings. By virtue of its cross-sectional design, conclusions about temporal relationships and the underlying patho-physiological mechanisms are necessarily limited. As such, an alternative interpretation of our findings may be that albuminuria and reduced eGFR could have caused or propagated the observed inflammatory response. This cause-and-effect relationship can only be established using large cohort studies. In the absence of such studies, our study has nevertheless deepened our insight into the possible aetiological factors. Another limitation is that renal function was estimated from creatinine-based equations since direct radioisotope GFR measurements on more than 300 patients included in this study would have represented a logistical challenge. Albuminuria was also determined on a single random urine sample and this may have reduced the power of our study. Although error in the determination of albuminuria and in the estimation of the true GFR would certainly have blunted any potential association, our positive findings, especially with regards to the TNF-α system, were in our opinion quite convincing.
Limitations aside, our study has several merits. This study was performed on a well-characterised group of patients and its substantial sample size afforded small p values that we then corrected using the conservative Bonferroni procedure. The latter measure gave us confidence that our positive findings were robust and therefore likely to represent real associations. In addition, we have improved upon previous studies by evaluating all three components of the TNF-α system (i.e. TNF-α, sTNFR1 and sTNFR2) instead of focusing only on one [3, 18] . Finally, we have also performed the appropriate statistical analyses with both albuminuria and eGFR as dependent variables, while at the same time, assessing the potential confounding effect of one renal trait on the other.
In conclusion, our study has furnished evidence that the activation of the TNF-α system is likely to exert independent effects on albuminuria and renal function in type 2 diabetes. While the relevance of our findings to diabetes care will require further investigation, our study suggests that exploration of newer therapies targeted at diminishing TNF-α-mediated chronic inflammation may prove beneficial in the prevention and treatment of diabetic nephropathy.
